Jezus-Eik, Belgium

John Surtees




Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Jezus-Eik, BE (2006 - 2009)
  • Jezus-Eik-Overijse, BE (2009)
  • Overijse, BE (2012)

Company Filing History:


Years Active: 2006-2012

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: John Surtees: Innovator in Chemical Processes

Introduction

John Surtees is a notable inventor based in Jezus-Eik, Belgium. He has made significant contributions to the field of chemistry, particularly in the development of processes for synthesizing important pharmaceutical compounds. With a total of 6 patents to his name, Surtees has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents, Surtees has developed a process for the preparation of 2-oxo-1-pyrrolidine derivatives. This invention relates to alternative methods for synthesizing compounds such as levetiracetam, brivaracetam, and seletracetam. Additionally, he has patented a new process for preparing 2-oxo-1-pyrrolidine derivatives of general formula (I), which includes specific substituents as defined in the patent specification.

Career Highlights

Throughout his career, John Surtees has worked with prominent companies in the pharmaceutical industry, including UCB S.A. and UCB Pharma S.A. His work has contributed to advancements in drug development and has had a lasting impact on the field.

Collaborations

Some of his notable coworkers include Anne-Catherine Burteau and Celal Ates. Their collaborative efforts have further enhanced the innovative work being done in the realm of chemical processes.

Conclusion

John Surtees is a distinguished inventor whose work in chemical processes has led to significant advancements in pharmaceutical synthesis. His contributions continue to influence the industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…